Waa maxay Microspheres-ka Embolic?

war

Waa maxay Microspheres-ka Embolic?

Tilmaamaha Isticmaalka (Sharax)

Microsfeer-yada Embolicwaxaa loogu talagalay in loo isticmaalo embolization-ka arteriovenous malformations (AVMs) iyo burooyinka hypervascular, oo ay ku jiraan fibroids-ka ilmo-galeenka.

 

1

Magaca Caadiga ah ama kan Caadiga ah: Kala-soocidda Microspheres-ka Polyvinyl Alcohol Embolic

Magaca: Qalabka Xididdada Dhiigga

Kala-soocidda: Fasalka II

Guddi: Wadnaha iyo Xididdada

 

Sharaxaadda Qalabka

 

Microspheres-ka Embolic waa microspheres hydrogel ah oo la cadaadin karo oo leh qaab caadi ah, dusha siman, iyo cabbir la cabbiray, kuwaas oo ka dhasha wax ka beddelka kiimikada ee walxaha polyvinyl alcohol (PVA). Microspheres-ka Embolic waxay ka kooban yihiin macromer laga soo qaatay alcohol polyvinyl (PVA), waana hydrophilic, lama nuugo karo, waxaana laga heli karaa cabbirro kala duwan. Xalka ilaalinta waa xalka 0.9% sodium chloride. Biyaha ku jira microsphere-ka si buuxda loo polymerized waa 91% ~ 94%. Microspheres-ku waxay u dulqaadan karaan cadaadiska 30%.

Microspheres-ka Embolic waxaa la siiyaa nadiif waxaana lagu xiraa dhalooyin galaas ah oo xiran.

Microspheres-ka Embolic waxaa loogu talagalay in loo isticmaalo embolization-ka arteriovenous malformations (AVMs) iyo burooyinka hypervascular, oo ay ku jiraan fibroids-ka ilmo-galeenka. Marka la xiro socodka dhiigga ee aagga la beegsanayo, burooyinka ama cilladaha ayaa ka gaajoonaya nafaqooyinka waxayna yareeyaan cabbirka.

Microspheres-ka Embolic waxaa lagu keeni karaa iyada oo loo marayo microcatheters-ka caadiga ah ee ku jira xadka 1.7-4 Fr. Waqtiga isticmaalka, Microspheres-ka Embolic waxaa lagu qasi karaa wakiil isbarbardhig aan ionic ahayn si loo sameeyo xal joojin ah. Microspheres-ka Embolic waxaa loogu talagalay isticmaalka hal mar waxaana la siiyaa nadiif ah oo aan pyrogenic ahayn. Qaabeynta qalabka ee Microsphere-ka Embolic waxaa lagu sharaxay Jadwalka 1 iyo Shaxda 2 ee hoose.

Noocyada kala duwan ee cabbirka ee Embolic Microspheres, noocyada cabbirka ee loo isticmaali karo embolization-ka fibroid-ka ilmo-galeenka waa 500-700μm, 700-900μm iyo 900-1200μm.

2

Shaxda: Qaabeynta qalabka ee Microspheres-ka Embolic
Badeecada
Koodhka
La hagaajiyay
Cabbirka (µm)
Tirada Tilmaamaha
Burooyinka Xididdada Dhiigga ee Sare/ Xididdada Dhiigga
Cilladaha
Fibroodka Ilmo-galeenka
B107S103 100-300 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa No
B107S305 300-500 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa No
B107S507 500-700 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
B107S709 700-900 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
B107S912 900-1200 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
B207S103 100-300 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa No
B207S305 300-500 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa No
B207S507 500-700 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa
B207S709 700-900 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa
B207S912 900-1200 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa

 

Badeecada
Koodhka
La hagaajiyay
Cabbirka (µm)
Tirada Tilmaamaha
Burooyinka Xididdada Dhiigga ee Sare/ Xididdada Dhiigga
Cilladaha
Fibroodka Ilmo-galeenka
U107S103 100-300 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa No
U107S305 300-500 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa No
U107S507 500-700 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
U107S709 700-900 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
U107S912 900-1200 1ml oo ah microspheres: 7ml 0.9%
soodiyaam koloriin
Haa Haa
U207S103 100-300 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa No
U207S305 300-500 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa No
U207S507 500-700 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa
U207S709 700-900 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa
U207S912 900-1200 2ml oo microspheres ah: 7ml 0.9%
soodiyaam koloriin
Haa Haa

Waqtiga boostada: Febraayo-27-2024